6 reasons the U.S. and Iran are on the brink of war There's still time for the U.S. and Iran to work out a solution. Axios · Feb 18
Fed minutes show widening divide over rate cuts Officials are split over how weak the labor market is and whether businesses will continue to pass along tariff-related costs to consumers. Axios · Feb 18
States test limits of ICE, CBP agent immunity The Trump administration has suggested federal agents possess "absolute immunity" from state-led prosecutions. Axios · Feb 18
Rev. Jamal Bryant: Jackson is "my blueprint" for Black churches in the Trump era For centuries, the Black church has been more than a place of worship — it's been a headquarters for resistance. Axios · Feb 18
Les Wexner's ties to Jeffrey Epstein, explained Wexner is set to testify as pressure mounts over the Epstein files. Axios · Feb 18
Survey: Americans aren't as racially divided as we think Inside America's quieter story of racial cooperation. Axios · Feb 18
Where Christian nationalism is most dominant in U.S. states A 50-state look at Christian nationalism. Axios · Feb 18
Trump moves closer to a major war with Iran There's little public debate about what could be the most consequential U.S. military action in a decade. Axios · Feb 18
Exclusive: Rubio's secret squeeze on Raul Castro's Cuba The talks show that the Trump administration sees 94-year-old revolutionary Raul Castro as the communist island's true decision-maker. Axios · Feb 18
Colbert slams CBS statement, accuses Paramount of not standing up to "bullies" "I'm just so surprised that this giant global corporation would not stand up to these bullies." Axios · Feb 18
The long game: Winter Olympians redefining their prime The Games are also a test of longevity. How long can greatness last? Axios · Feb 18
Scoop: Democrats eye forced vote to censure GOP Rep. Randy Fine over anti-Muslim post A censure vote "could likely happen," one senior House progressive told Axios. Axios · Feb 17
Meta commits billions to Nvidia chips The deal includes GPU and CPU chips, signaling the next phase of AI. Axios · Feb 17
Bayer reaches $7.25B settlement over Monsanto's Roundup accusations The deal comes as Bayer awaits a Supreme Court ruling that could determine whether Roundup stays on the market in the U.S. Axios · Feb 17
Axios · Feb 17 Police arrest 18-year-old suspect for allegedly running at U.S. Capitol with shotgun The shotgun was loaded and the suspect was wearing a "tactical vest," the Capitol Police chief said.
Axios · Feb 17 Colbert defies CBS over interview with Texas Senate candidate James Talarico The network's lawyers told the show it couldn't air the interview, Colbert said.
Axios · Feb 17 After Super Bowl ad, consumers rethink the tradeoffs of home surveillance tech What once felt like a personal security upgrade now feels to many like participation in a broader law enforcement enforcement apparatus that they didn't sign up for.
Axios · Feb 17 Zelensky says Ukrainian public won't let him hand Russia territory "Emotionally, people will never forgive this," Zelensky told Axios.
Axios · Feb 17 U.S. and Iran say progress made in Geneva nuclear talks The Trump administration is amassing U.S. forces in the Middle East for possible military action against Iran.
Axios · Feb 17 "The subpoenas are coming," bipartisan firm warns corporate America "It's going to be so much worse than they expect," Miller tells Axios.
Axios · Feb 17 In photos: Jesse Jackson's life, activism and politics His career in activism and politics coincided with a national transformation in civil rights and inequality
Axios · Feb 17 Civil rights icon Jesse Jackson dies at 84 He will go down in history as one of this country's most influential civil rights leaders.
Axios · Feb 17 How Trump saved TikTok: Backstory of a 2-year campaign One chart, cleverly plopped on the first page, jumped out at Trump. "I'm more popular than Taylor Swift," he crowed.
Axios · Feb 17 The AI trade is swallowing the market If the tech sector stumbles, so does everything else.
Axios · Feb 17 The narrow slice of data that worries biosecurity experts Once high-risk biological data hits the open web, it can't be recalled.